NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Current Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2013 | - |
Mar2012 | - |
How is Current Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2013 | - | 0 | |
Mar2012 | - | - |
Compare Current Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹375.3 Cr | -4.4% | 3.4% | -0.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,113.6 Cr | -4% | -5% | 14.3% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,403.9 Cr | -4.2% | -15% | 33.8% | Stock Analytics | |
VENKYS (INDIA) | ₹2,255.7 Cr | -1.3% | -0.4% | -21.3% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,418.8 Cr | -3.9% | -1.8% | -30.6% | Stock Analytics | |
INDO US BIOTECH | ₹303.6 Cr | 0.4% | 2.2% | -30.7% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -4.4% |
3.4% |
-0.8% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses